“A Critical Review on Bioanalytical Methods Impurity Profiling, Degradation Study of Empagliflozin and Linagliptin ” (2022) Journal of Pharmaceutical Negative Results, pp. 3831–3841. doi:10.47750/pnr.2022.13.S08.478.